Adapting to the Appetite Shift: Food Industry Strategies Amid the Rise of GLP-1 Drugs According to the World Obesity Federation (2024), estimates for global levels of obesity (high BMI) suggest that nearly 3.3 billion adults may be affected by 2035, compared with 2.2 billion in 2020
Quelle: In dieser Tierstudie erhielten Ratten Ipamorelin in verschiedenen Dosierungen
GLOW (marketed under names including Klow and various pharmacy-specific brand designations) is a compounded injectable preparation that combines peptide and antioxidant ingredients intended to support skin appearance, texture, and pigmentation
Lam CS, Ramasundarahettige C, Branch KR, Sattar N, Rosenstock J, Pratley R, et al
The Evidence Gap: Clinical Trials and What They Actually Show The evidence gap between GHK-Cu and retinoids is real, and any honest comparison of GHK-Cu vs retinol for anti-aging must address it plainly